PMID: 9161946May 1, 1997Paper

Omeprazole for severe reflux esophagitis in children

Journal of Pediatric Gastroenterology and Nutrition
C De GiacomoR Fiocca

Abstract

Severe esophagitis is a rare complication of gastroesophageal reflux in children. In adults, omeprazole therapy of severe erosive esophagitis has become the gold standard short-term treatment of the disease. In children, data on its use are limited, and problems about the dosage are unresolved. The aim of this study was to evaluate the efficacy of a simplified, body-weight-based daily dosage of omeprazole in children with severe esophagitis. Ten children (median age 75.6 months; range 25-109 months) with severe esophagitis were prospectively investigated. All patients were evaluated by endoscopy, histology, and 24-h pH-metry study before and after 3 months of omeprazole. The starting dose of omeprazole was 20 mg as a single daily dose in children weighing less than 30 kg, and 40 mg daily for those weighing over 30 kg. A significant improvement in all the children was demonstrated after 3 months of treatment by clinical, endoscopic, and pH-metry assessment. However, histologic study failed to show significant improvement of both inflammatory and hyperplastic findings. Relapse occurred in six of 10 patients after discontinuation of therapy. Omeprazole is effective in the short-term treatment of severe oesophagitis in children. Th...Continue Reading

References

Jan 1, 1990·Scandinavian Journal of Gastroenterology. Supplement·G N TytgatR H Schotborgh
May 1, 1987·Archives of Disease in Childhood·C Di LorenzoS Cadranel
Dec 1, 1993·Archives of Disease in Childhood·S CucchiaraS Auricchio
Jul 1, 1993·The Journal of Pediatrics·T S Gunasekaran, E G Hassall
Apr 1, 1996·Journal of Pediatric Gastroenterology and Nutrition·E Hassall
Apr 1, 1996·Journal of Pediatric Gastroenterology and Nutrition·Y Vandenplas

❮ Previous
Next ❯

Citations

Apr 2, 2008·Current Gastroenterology Reports·Maria E Perez, Nader N Youssef
Jun 18, 1998·Otolaryngologic Clinics of North America·V M Tsou, P R Bishop
Jun 8, 2001·Clinical Therapeutics·A E ZimmermannD Levine
Nov 19, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·F MarchettiA Ventura
Aug 30, 2001·Journal of Pediatric Gastroenterology and Nutrition·C D RudolphUNKNOWN North American Society for Pediatric Gastroenterology and Nutrition
Dec 20, 2003·Journal of Pediatric Gastroenterology and Nutrition·Richard B Colletti, Carlo Di Lorenzo
Dec 20, 2003·Journal of Pediatric Gastroenterology and Nutrition·Colin D Rudolph
Nov 11, 1999·Current Opinion in Pediatrics·J S Evans, S Huffman
Jun 10, 2003·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·K M OlsenD S Collier
Feb 4, 2006·Journal of Pediatric Gastroenterology and Nutrition·Marian D PfefferkornJoseph F Fitzgerald
May 6, 2005·Clinical Pharmacokinetics·Catherine LitalienChristophe Faure
May 31, 2008·Acta chirurgica Iugoslavica·A SretenovićZ Krstić
Aug 8, 2007·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G LombardiL Dall'Oglio
Jul 23, 2008·Developmental Disabilities Research Reviews·Peter B Sullivan
Oct 22, 2013·Expert Opinion on Pharmacotherapy·Harohalli Shashidhar, Vasundhara Tolia
Sep 27, 2000·Baillière's Best Practice & Research. Clinical Gastroenterology·G P Davidson, T I Omari
Feb 27, 2007·The American Journal of Gastroenterology·Gabriella BocciaAnnamaria Staiano
Apr 30, 1998·The Annals of Pharmacotherapy·J K WaltersB G Katona
Aug 9, 2002·Clinical Pediatrics·David A Gremse
Nov 25, 2014·The Cochrane Database of Systematic Reviews·Mark TigheR Mark Beattie
Jun 27, 2007·Journal of Pediatric Gastroenterology and Nutrition·Jonathan BishopMike Thomson
Sep 3, 2010·Journal of Pediatric Gastroenterology and Nutrition·Marta IlluecaPer Lundborg
Nov 20, 1998·Journal of Pediatric Gastroenterology and Nutrition·D M Israel, E Hassall
Jan 7, 2003·Paediatric Drugs·Troy E Gibbons, Benjamin D Gold

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
M T FrancoS Cucchiara
© 2021 Meta ULC. All rights reserved